GlassScriptPhysician profile
Michael-Vu T DO
NPI 1922419738
$3,529.11
in general payments reported to CMS, 2019-2025
17 companies · $664 in 2025
The $664 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $192 · 2021: $265 · 2022: $791 · 2023: $488 · 2024: $611 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653 · Entertainment: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.25 |
| Entertainment | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $771.99 | 2022-2025 | Infuse, Biotrue One Day, Miebo |
| Coopervision INC. | $674.75 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Alcon Vision LLC | $475.08 | 2021-2025 | Total30, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $344.15 | 2021-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $302.45 | 2019-2020 | |
| Oyster Point Pharma, INC. | $172.90 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $147.10 | 2020-2022 | |
| Shire North American Group INC | $135.43 | 2019 | |
| Optos, INC. | $109.00 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Eyevance Pharmaceuticals LLC | $105.85 | 2019 | |
| Quidel Corporation | $98.78 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $87.81 | 2024-2025 | Xdemvy |
| Lkc Technologies, INC. | $27.27 | 2023 | |
| Visioneering Technologies, INC. | $26.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.36 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $15.01 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael-Vu DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.